|
|
| Research article summary (published 30 Aug 2009): |
Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Full Abstract
In prion diseases the normal cellular isoform of prion protein (PrP), denoted PrP(C), is converted into an abnormal, pathogenic isoform of PrP (PrP(Sc)). Diagnostic tools for prion diseases are conventionally based on the detection of protease-resistant PrP (PrP(res)) after proteinase K digestion. However, recent studies have revealed that protease-sensitive abnormal PrP (sPrP(Sc)) also exists in significant amounts in brains suffering from prion diseases. Here, we designed a simplified size-exclusion gel chromatography assay, using disposable spin columns to examine PrP aggregates in the course of the disease, without proteinase K digestion. Brain homogenates of NZW mice, inoculated intracranially with Fukuoka-1 strain, and which died at around 120 days post-inoculation, were assayed by this gel-fractionation method and eluted PrP molecules in each fraction were detected by western blot analysis. Oligomeric PrP molecules were well separated from monomers, as predicted. A conventional protease-digestion assay was also performed to detect PrP(res) and revealed that the ratio of PrP(res) to total PrP increased drastically from 105 days. However, the increase of PrP oligomers became significant from 90 days. These PrP oligomers in the early disease stage would, therefore, be sPrP(Sc) molecules that might affect the disease pathology, such as spongiform change and abnormal PrP deposition. We also observed that the resistance of PrP oligomers to proteinase K and insolubility in phosphotungstic acid precipitation increased with disease progression, which suggests that PrP oligomers are not clearly distinguished from cellular PrP or PrP(res) but may overlap in a continuous spectrum. Our study casts light on the ambiguity of the definition of PrP(Sc) and indicates that the abnormality of PrP molecules should be determined from various perspectives, more than protease resistance.
Author information
Author/s: Sasaki, Kensuke (K); Minaki, Haruhiko (H); Iwaki, Toru (T);
Affiliation: Department of Neuropathology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ksasaki(-atsign-)np.med.kyushu-u.ac.jp
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: The Journal of pathology (J Pathol), published in England. (Language: eng)
Reference: 2009-Sep; vol 219 (issue 1) : pp 123-30
Dates: Created 2009/08/13; Completed 2009/10/09;
PMID: 19479969, status: MEDLINE (last retrieval date: 10/9/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Prion proteins: a biological role beyond prion diseases.
30 Jul 2007 - In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie.
29 Nov 2008 - Dynamic analyses of PrP and PrP(Sc) in brain tissues of golden hamsters infected with scrapie strain 263K revealed various PrP forms.
28 Feb 2004 - Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
31 Jul 2002 - Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
27 Feb 2006 - Sonication induced intermediate in prion protein conversion.
30 Dec 2007 - Quantitative profiling of the pathological prion protein allotypes in bank voles by liquid chromatography-mass spectrometry.
25 Sep 2006 - Biochemistry and structure of PrP(C) and PrP(Sc).
30 Dec 2002 - Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.
30 Dec 2004 - Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
30 Oct 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.